US 12012455
Human monoclonal antibodies specific for FLT3 and uses thereof
granted A61KA61K2039/505A61K47/6849
Quick answer
US patent 12012455 (Human monoclonal antibodies specific for FLT3 and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K47/6849, A61K47/6929, A61P